Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Microfluidics help lab-on-a-chip development skyrocket

Microfluidics help lab-on-a-chip development skyrocket

Bionomics licences childhood epilepsy test

Bionomics licences childhood epilepsy test

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

New biotech alliance to focus on diseases of nerve injury and pain

New biotech alliance to focus on diseases of nerve injury and pain

IBM and Cellomics offer new solution to accelerate cell-based drug discovery

IBM and Cellomics offer new solution to accelerate cell-based drug discovery

Effects of oxidative stress on atherosclerosis

Effects of oxidative stress on atherosclerosis

Cyntellect issued patent covering LaserFect(TM) technology

Cyntellect issued patent covering LaserFect(TM) technology

Research collaboration to discover novel oral drugs for the treatment of viral infections

Research collaboration to discover novel oral drugs for the treatment of viral infections

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science

Neuro3d identifies candidate compound

Neuro3d identifies candidate compound

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Natural products to be developed as anti-cancer therapeutics

Natural products to be developed as anti-cancer therapeutics

Exelixis files new drug application for a proprietary novel anticancer compound

Exelixis files new drug application for a proprietary novel anticancer compound

Drug for multiple sclerosis prevented disease development when tested on animal models

Drug for multiple sclerosis prevented disease development when tested on animal models

Outsourcing the way to control spiraling R&D budgets in drug industry

Outsourcing the way to control spiraling R&D budgets in drug industry

New statistical techniques for cancer diagnosis

New statistical techniques for cancer diagnosis

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax